János Pethö

Title: János Pethö: Innovator in Pharmaceutical Chemistry

Introduction

János Pethö is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new crystalline forms of medications. His work has implications for the treatment of psychotic conditions, showcasing the importance of innovation in healthcare.

Latest Patents

János Pethö holds a patent for "Polymorphs of olanzapine hydrochloride." This invention relates to new crystalline forms I, II, and III of 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]-benzodiazepine hydrochloride. The patent outlines a process for the preparation of these forms and pharmaceutical compositions containing them. These new polymorphic forms are useful as active ingredients for the treatment of psychotic conditions. He has 1 patent to his name.

Career Highlights

Throughout his career, János Pethö has worked with prominent companies in the pharmaceutical industry. He has been associated with Egis Pharmaceuticals PLC and Egis Gyógyszergyár Zrt., where he has contributed to various research and development projects. His expertise in pharmaceutical formulations has been instrumental in advancing therapeutic options.

Collaborations

János Pethö has collaborated with esteemed colleagues, including József Barkóczy and Péter Kótay Nagy. These partnerships have fostered innovation and have been crucial in the development of new pharmaceutical solutions.

Conclusion

János Pethö's contributions to pharmaceutical chemistry, particularly through his patent on olanzapine hydrochloride polymorphs, highlight his role as an innovator in the field. His work continues to impact the treatment of psychotic conditions, demonstrating the vital link between invention and healthcare advancement.